Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336890 · ClinicalTrials.gov registry record
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
A clinical trial of Asthma in Children and Premature Birth, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05336890: Recruiting study of Asthma in Children and Premature Birth, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05336890 is a study of Asthma in Children and Premature Birth that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 500 participants, above the 194-participant average among 44 other Asthma in Children trials with a reported enrollment target (158% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05336890, a study of Asthma in Children and Premature Birth, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite improved survival of extremely premature infants in recent decades, neonatal intensive care unit (NICU) graduates are diagnosed with asthma, sleep disordered breathing (SDB) in childhood, and neurodevelopmental impairments (NDI) at significant rates, disproportionate to their term peers. Early detection and intervention are critical to mitigate the impact of these impairments. Mechanisms leading from premature birth to these undesirable outcomes remain unclear, and accurate prognostic measures are lacking. This study wants to learn if these problems are related to certain patterns of breathing that babies had while they were in the NICU.
Primary Outcome
Doctor diagnosed asthma as assessed in the International Study on Asthma and Allergies in Childhood questionnaire (ISAAC)
Conditions Studied
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06-30 |
What NCT05336890 shows while recruiting
NCT05336890 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 194-participant average among 44 other Asthma in Children trials with a reported enrollment target (158% higher).
The record links to 4 conditions, with Asthma in Children appearing as the primary indexed condition, and to 0 interventions.
NCT05336890 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05336890 about?
NCT05336890 is a clinical study titled "Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age". Despite improved survival of extremely premature infants in recent decades, neonatal intensive care unit (NICU) graduates are diagnosed with asthma, sleep disordered breathing (SDB) in childhood, and neurodevelopmental impairments (NDI) at significant rates, disproportionate to their term peers. Ear...
What is the current status of trial NCT05336890?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-11-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05336890 study?
This clinical trial studies the following conditions: Asthma in Children, Premature Birth, Neurodevelopmental Disorders, Sleep Disordered Breathing.
Who is sponsoring clinical trial NCT05336890?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05336890 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05336890's enrollment target sits among peer trials
500 3rd of 44 higher than 39 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI